Skip to main content
  • Forums
  • Log in
  • Contact us
  • Policy
www.notifylibrary.org
  • The Notify Project
    • History
    • Who we are
    • Interviews
        1. Health authorities
        2. The Experts
    • Useful links
    • Global consultation reports
  • Search Library
    • Search tutorial
    • Adverse occurrence search
    • Reference search
    • Bibliographic list
        1. Authors
        2. Keywords
    • Add or update record
    • Editorial Group Tools
        1. MPHO taxonomy
        2. Adv. occurrence taxonomy
        3. Imputability table
        4. VIDEO TUTORIAL
    • Database content analysis
  • Notify Booklet
    • 1 INTRODUCTION
    • 2 THE V&S CHAIN FOR MPHOs
    • 3 VIGILANCE AND SURVEILLANCE: HISTORY AND BASIC ELEMENTS
    • 4 MEDICAL PRODUCTS OF HUMAN ORIGIN (MPHO) - DONATION AND ETHICS
    • ANNEX 1. Notify Library - MPHO type taxonomy
    • 5 TOWARDS A GLOBAL GOVERNANCE OF MPHO
    • 6 THE V&S SYSTEM IS PRIMARILY A RESPONSIBILITY FOR HEALTH AUTHORITIES
    • 7 ORGANIZATION FOR A COMPREHENSIVE - VIGILANCE & SURVEILLANCE SYSTEM
    • 8 VIGILANCE & SURVEILLANCE - RECOGNITION RELIES ON HEALTH CARE STAFF
    • 9 INVESTIGATING OCCURRENCES THAT COULD CAUSE HARM - LEARNING FROM ERRORS
    • 10 PROJECT NOTIFY
    • 11 THE NOTIFY DATABASE - LEARNING FROM VIGILANCE
    • 12 RISKS ASSOCIATED WITH LIVING DONATION
    • 13 HARM TO RECIPIENT - INFECTIONS
    • 14 HARM TO RECIPIENT - NON INFECTIOUS BLOOD TRANSFUSION REACTIONS
    • 15 HARM TO RECIPIENTS - MALIGNANCY
    • 16 HARM TO RECIPIENTS - GENETIC TRANSMISSIONS - HPC
    • 17 HARM TO RECIPIENTS - GENETIC TRANSMISSIONS - gamets and embryos
    • 18 CHARACTERISTICS, HANDLING AND CLINICAL ERRORS
    • 19 TRACEABILITY, AN ABSOLUTE PRE-REQUISITE FOR MPHO SAFETY
    • ANNEX 2. Notify Library - Adverse occurrence type taxonomy
    • REFERENCES
  • Background Documents
Home / Bibliography

Bibliography

Export 5 results:
Filters: Author is Nalesnik,M. A.  [Clear All Filters]
2011
Nalesnik MA, Woodle ES, DiMaio JM, Vasudev B, Teperman LW, Covington S, et al. Donor-Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk. Am J Transplant. 2011;11(6):1140-1147.
Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. Am J Transplant. 2011;11(6):1123-30.
2010
Blumberg E, Green M, Covington SG, Taranto S, Taylor K, Parker K, et al. Donor Derived Bacterial Infections: Report From the Disease Transmission Advisory Committee (DTAC). In: 48th Annual Meeting of the Infectious Diseases Society of America. Vancouver, British Columbia. October 21 – 24, 2010.; 2010.
2009
Ison MG, Hager J, Blumberg E, Burdick J, Carney K, Cutler J, et al. Donor-Derived Disease Transmission Events in the United States: Data Reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. American Journal of Transplantation. 2009;9(8):1929-1935.
1999
Shapiro R, Nalesnik MA, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999;68(12):1851-4.
↑
  • Forums
  • Log in
  • Contact us
  • Policy

Disclaimer

The cases, bibliography and associated comments included in this website and database have been provided by experts worldwide and reviewed by voluntary editorial working groups. The data and information is not guaranteed to be complete or to be fully up to date at any particular moment and it reflects the knowledge and views of the experts participating, not those of the World Health Organisation or the Italian National Transplant Centre.